Related Experiment Videos
Ofloxacin: in-vitro activity against clinical isolates
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy
|December 1, 1985
Summary
Ofloxacin, a new quinolone antibiotic, shows strong in-vitro activity against common urinary tract bacteria. It is particularly effective against Enterobacter aerogenes, a difficult-to-treat pathogen.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Urinary tract infections (UTIs) are common and can be caused by various bacteria.
- Some bacterial strains, like Enterobacter aerogenes, are notoriously difficult to treat with existing antibiotics.
- New antimicrobial agents are needed to combat resistant or hard-to-eradicate pathogens.
Purpose of the Study:
- To evaluate the in-vitro antibacterial activity of ofloxacin, a novel quinolone derivative.
- To determine the efficacy of ofloxacin against a range of bacterial strains isolated from urine samples.
- To assess the potential of ofloxacin in treating infections caused by challenging bacteria such as Enterobacter aerogenes.
Main Methods:
- In-vitro susceptibility testing was performed on 273 bacterial isolates from urine.
- Standard microbiological techniques were employed to culture and identify bacterial strains.
- The activity of ofloxacin was compared against established antibiotic classes.
Main Results:
- Ofloxacin demonstrated significant in-vitro activity against the majority of Gram-negative bacteria tested.
- Exceptional efficacy was observed against Enterobacter aerogenes isolates.
- The compound showed promising results where third-generation cephalosporins were less effective.
Conclusions:
- Ofloxacin is a potent antimicrobial agent with broad-spectrum activity against Gram-negative urinary pathogens.
- Its remarkable activity against Enterobacter aerogenes suggests a valuable role in treating difficult UTIs.
- Ofloxacin represents a promising therapeutic option for managing complex bacterial urinary tract infections.